Protocols for quantitative assessment of lymphocyte chemotaxis and migration are important tools for immunology research. Here, an in vitro protocol is described that permits real-time, multiplexed evaluation of cell migration, as well as a complementary in vivo technique enabling tracking of native cells to spleen.
Chemotaxis is migration along a specific chemical gradient1. Chemokines are chemotactic cytokines that promote cellular trafficking with anatomic and temporal specificity2. Chemotaxis is a critical function of lymphocytes and other immune cells that can be quantitatively assessed in vitro. This manuscript describes methods that permit the evaluation of chemotaxis, both in vitro and in vivo, for diverse cell types including cell lines and native cells. The in vitro, plate-based format permits the comparison of several conditions simultaneously in real-time, and can be completed within 1-4 h. In vitro assay conditions can be manipulated to introduce agonists and antagonists, as well as differentiate chemotaxis from chemokinesis, which is random movement. For in vivo trafficking assessments, immune cells can be labeled with multiple fluorescent dyes and used for adoptive transfer. The differential labeling of cells allows for mixed cell populations to be introduced into the same animal, thereby decreasing variance and reducing the number of animals required for an adequately powered experiment. Migration into lymphoid tissue occurs in as little as 1 h, and multiple tissue compartments can be sampled. Flow cytometry following tissue harvest allows for a rapid and quantitative analysis of the migratory patterns of multiple cell types.
Robust immunity requires the complex temporal and spatial coordination of a myriad of cell types in order to respond appropriately to injury, infection and generate self-tolerance. Several dozen chemokine receptors and their corresponding ligands have been discovered and characterized providing molecular mechanisms by which specific cells can be directed into a specific tissue at a specific time. Thus, studying chemotaxis and migration is an indispensable component of immunology research. Indeed, the described in vitro assay was recently used as a screening tool to identify a chemotactic cofactor that accelerates chemotaxis of T-cells toward C-C chemokines 19 and 213. The purpose of the methods described here are to permit quantitative assessments of immune cell chemotaxis in vitro and in vivo.
The Boyden (cell migration and invasion) chamber assay is an inexpensive, reproducible, and rapid method for assessing cell migration4,5. In the standard assay, the upper chamber is seeded with cells, and is separated by a porous insert from a lower chamber, into which the cells migrate. At the desired time, cells that have migrated to the underside of the insert can be fixed and stained for quantitation by light microscopy. However, such measurements constrain data collection to a single end point, which precludes dynamic data collection and can require extensive optimization to determine the optimal time point for analysis. Here, several adaptations are described that permit real-time, quantitative and multiplexed measurements of chemotaxis in vitro.
For in vivo studies, a functional end point is used, namely the specific accumulation of cells in a given tissue compartment. Pre-labeled donor cells are introduced into recipient animals through adoptive transfer. These donor cells can subsequently be identified by flow cytometry after recipient tissue harvest. Also presented is a co-labeling strategy that allows for the determination of trafficking of different cell types within a single recipient animal. This method eliminates the inter-animal variation from cell injection, and accounts for physiologic inter-animal variability.
All procedures were approved by Rockefeller University's Institutional Animal Care and Use Committee. All animals were housed under specific pathogen-free conditions.
1. In Vitro Chemotaxis
2. Adoptive Transfer of Murine Lymphocytes
When using calcein-AM dye, visual inspection of cells will confirm label uptake (Figure 1). Automated fluorescent readings will track migration as cells transit onto the underside of the insert over time. These data clearly show an induction of cell migration towards MCP-1, as well as an augmentation of this response by serum (Figure 2A). Depending on the strength of the migratory stimulus, there is a lag of at least 15 min prior to an increase in signal. The fluorescent signal may peak and then gradually decline. This represents a net decrease in the number of cells adhering to the underside of the insert as cells pass into solution into the lower chamber at a rate faster than that of cells migrating from the upper chamber. Stronger migratory stimuli typically result in a) earlier onset of a rise in fluorescence values; b) faster rate of increase in fluorescence; and c) higher peak fluorescence values. Representative images acquired by inverted fluorescence microscopy are also shown (Figure 2B), with quantitation of cell counts (Figure 2C).
For in vivo studies utilizing more than one fluorescent label, it is important to quantitate the relative proportion of cell populations in the input material. This accounts for the variance in mixing cell populations for injection (Figure 3). In this case, the ratio of green- and orange-fluorescent cells was 0.97:1. Thus, to account for this slight imbalance, green-fluorescent cell counts were divided by 0.97 to index their numbers in proportion to the input material. After quantifying labeled cells by flow cytometry, trafficking can be quantified as the number of labeled cells recovered divided by the total number of cells recovered.
These results demonstrate the advantage of using the dual-color strategy, which eliminates the effect of varying injection efficacy; while there is considerable variance of recovered cells between animals, for any given animal the ratio of green-fluorescent to orange-fluorescent cells is approximately equal (Figure 4). These results are expected, as the two cell populations were treated identically, but various perturbations can be tested for their effect on lymphocyte homing. Deviation from the line of identity would indicate different migratory capabilities of the specific cell populations. Additionally, multiple cell subsets can be determined by staining the recovered cells for the desired proteins. Here, T-cells, indicated by CD3 staining, and B-cells, indicated by CD19 staining are also recovered with equal proportions of green- to orange-fluorescent cells.
Figure 1: Cell labeling. Visual inspection of the cell pellet after labeling confirms adequate uptake of the fluorescent dye (left), in contrast to prior to labeling (right). Please click here to view a larger version of this figure.
Figure 2: Quantification of in vitro Migration. (A) Representative data (mean ± standard error) acquired in real-time from a plate reader comparing 3 conditions: media (control), chemokine (MCP-1, 75 ng/mL) or chemokine with serum (MCP-1, 75 ng/mL and bovine serum, 2.7 % v/v in buffer). Readings were acquired from the underside of the plate every 3 min with an excitation wavelength of 485 nm and detection wavelength of 520 nm. (B) Representative micrographs at 4X magnification of the underside of the insert at 1 h, which allows direct visualization of migrating cells. Scale bars = 500 µm (yellow). (C) Quantification of cell number per low-powered field (LPF; 4X) using ImageJ software. Please click here to view a larger version of this figure.
Figure 3: Stained input cells. Flow cytometry plot showing the ratio of the two differentially stained cell populations in the injected cell input from step 2.2.2.1. The ratio determined from this plot serves to correct for variance introduced during the initial mixing of the two populations and is used to adjust cell counts during downstream data analysis. Please click here to view a larger version of this figure.
Figure 4: Ratio of labeled cells recovered from spleens of recipient animals. The proportions of green-fluorescent or orange-fluorescent cells are presented as a percentage of the total recovered splenocytes, with each data point representing a single recipient animal. The total labeled cells are shown (triangle), as well as the subsets that also stained positive for the cell surface markers CD19 (square) or CD3 (circle). Dashed line is the line of identity where the ratio between colors is equal to 1. Please click here to view a larger version of this figure.
Quantification of immune cell migration can be accomplished using simple and rapid assays both in vitro and in vivo. We demonstrate the in vitro chemotaxis of human monocytes in response to a MCP-1 gradient and augmentation by serum. In vivo, donor murine splenocytes were differentially labeled and following adoptive transfer, were recovered from recipient animals.
Using a plate reader has the advantage of sampling several time points (as frequently as every 30 s) and automating the quantitation of migrating cells. This obviates the need to choose a single time point for evaluation and avoiding the more labor-intensive methods of manual counting of individual wells. Moreover, this method provides more dynamic information than can be gathered by microscopy. During analysis it must be kept in mind that cells will fall off the insert into the bottom chamber, and will not contribute to the fluorescence intensity. Thus, the number of cells on the underside of the insert, as indicated by relative fluorescence, will be a function of the rate of migration and the rate by which cells fall off the insert.
Larger cells may require an insert with larger pores, and 8 μm porous inserts are available. Smaller cells (including native lymphocytes) may not be bright enough to be reliably detected by a fluorimeter and may require evaluation by microscopy, particularly for small changes in chemotaxis. Some cell types may pass rapidly into the lower chamber solution and not have a long enough residence time on the insert to be detected, resulting in a flattened curve. In this case, cells can be quantified by cytometry directly from the lower chamber solution, or a matrix-coated insert can be used to lengthen transit time in addition to using an insert with smaller pores (e.g. 1 μm).
Critical to these assays is the identification of robust migratory conditions. For in vitro studies, the cell type studied must be capable of responding to a chemoattractant, and necessary co-factors must be considered. Optimization may be required for cell density introduced in the upper chamber. In general, a higher density will result in a stronger signal, but this needs to be balanced against a higher non-specific migration signal. Testing a range of chemoattractant concentrations may also help identify a suitable temporal window for capturing migration.
This method could also be adapted to use multiple colors. This would conceivably reduce variability, as well as increasing the number of conditions that can be included in a single assay. The primary consideration here is the brightness of the fluorescent dyes. Calcein-AM is very bright and therefore easily detected by both microscope and plate reader applications. Whereas the dyes used for in vivo studies were not readily detected by microscopy and produced high background; presumably this would also preclude accurate plate reader detection.
For in vivo studies, the health of donor cells is important to preserve their migratory function. The harvest of donor cells should be done as part of non-survival surgery, rather than sacrificing the donor animal and then harvesting cells, which increases the likelihood of ischemia and cell death. The time between injection and harvest is an important consideration for experiments in which different cell populations are used; the level of divergence or similarity between cell populations may change over time. Processing time after harvest from the donor until injection into the recipient should be minimized. Also, donor/recipient compatibility is also critical. Human cells will be rapidly rejected by mice, though intra-species allogeneic cells are well-tolerated over short periods. For example, we do not find a difference in migrating cells with C57BL/6J or BALB/cJ donors are used with C57BL/6J recipients over a period of 1 h.
This in vivo method is useful for assessing differences in migratory capability. Both input cells and recipient animals can be subject to pharmacological or other perturbations. Similarly, recipient animals can be exposed to infectious or inflammatory stimuli, or other treatments that affect lymphocyte trafficking12. This protocol can also be readily applied to transgenic mouse lines. In particular, those expressing fluorescent proteins would obviate the need for labeling and could potentiate multiplexing strategies.
It is important to note that the time in which different cell populations are mixed prior to injection should be reduced as much as possible. Differentially labeled cell populations should be mixed only after the recipient animals have been fully anesthetized and are ready for injection. The dyes present in the different populations can mix, resulting in unclear separation between the two when analysed by flow cytometry. In addition, different treatment conditions can affect the untreated cells during this time. For example, agents that bind to the cell surface may be transferred to the untreated cells, thereby confounding results.
The authors have nothing to disclose.
This work was supported by the Bernard L. Schwartz Program for Physician Scientists at The Rockefeller University, the Robertson Therapeutic Development Fund at The Rockefeller University, and the Sackler Center for Biomedicine and Nutrition Research at The Rockefeller University.
RPMI-1640 | Thermo Fisher Scientific | 11875-093 | |
HEPES | Thermo Fisher Scientific | 15630-080 | |
Fetal Bovine Serum | ATCC | 30-2020 | |
Cell culture flask | Corning | 353136 | |
Calcein AM | Thermo Fisher Scientific | C1430 | Excitation: 485nm, Emission: 520nm |
Cell culture dish | Corning | 1007 | |
24 well plate | Corning | 353504 | |
Fluoroblok Fibronectin Insert | Corning | CB354597 | |
15 mL conical tube | Corning | 352097 | |
Bovine Serum Albumin | Cell Signaling Technology | 9998S | |
Human Recombinant MCP-1 | Peprotech | 300-04 | |
Adult bovine Serum | Sigma | B9433 | |
HBSS with calcium and magnesium; no phenol red | Thermo Fisher Scientific | 14025-092 | |
SpectraMax M2e plate reader | Molecular Devices | ||
Olympus IX71 inverted fluorescence microscope | Olympus | ||
Isothesia | Henry Schein animal health | 11695-6776-2 | Isofluorane anesthesia |
Cell strainer 40um nylon | Falcon Corning | 352340 | |
ACK lysing buffer | Quality Biological | 118-156-101 | |
CellTracker Orange CMTMR Dye | Thermo Fisher Scientific | C2927 | Excitation: 541nm, Emission: 565nm |
CellTracker Green CMFDA Dye | Thermo Fisher Scientific | C2925 | Excitation: 485nm, Emission: 520nm |
5ml syringe | BD Syringe | 309646 | |
1ml TB syringe | BD Syringe | 309625 | |
THP-1 cell line | ATCC | TIB-202 | |
Brilliant Violet 421 anti-mouse CD3 Antibody | Biolegend | 100228 | Excitation: 405nm, Emission: 421nm |
Brilliant Violet 605 anti-mouse CD19 Antibody | Biolegend | 115540 | Excitation: 405nm, Emission: 603nm |
96-well round bottom plate | Corning | 353077 | |
LSRII | BD Biosciences | Flow cytometer |